Eloxx Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eloxx Pharmaceuticals

15/08/2022 15:10

* Eloxx Pharmaceuticals Inc  ELOX.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 10 cents per share.
    * Reported revenue was zero​; analysts expected $2.33
million. 
    * Eloxx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Eloxx Pharmaceuticals Inc shares had risen by 20.4% this
quarter and lost 54.0% so far this year.
    * The company reported a quarterly loss of $10.62 million.
    * Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $1.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 02:10 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.10          -0.12          Missed
 Mar. 31 2022      -0.09          -0.13          Missed
 Dec. 31 2021      -0.12          -0.14          Missed
 Sep. 30 2021      -0.13          -0.11          Beat